| Urea, N-[5-chloro-2-[2-[(2R)-4-[(4-fluorophenyl)Methyl]-2-Methyl-1-piperazinyl]-2-oxoethoxy]phenyl]- |
(R)-1-(5-氯-2-(2-(4-(4-氟苄基)-2-甲基哌嗪-1-基)-2-氧代乙氧基)苯基)脲 |
217645-70-0 |
| Vipadenant |
3-(4-氨基-3-甲基苄基)-7-(呋喃-2-基)-3H-[1,2,3]三唑并[4,5-D]嘧啶-5-胺 |
442908-10-3 |
| Tofacitinib citrate |
枸橼酸托法替尼 |
540737-29-9 |
| pilaralisib |
2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺酰基]苯基]-2-甲基丙酰胺 |
934526-89-3 |
| CP-456773 sodium |
N-[[(1,2,3,5,6,7-六氢-S-引达省-4-基)氨基]羰基]-4-(1-羟基-1-甲基乙基)-2-呋喃磺酰胺单钠盐 |
256373-96-3 |
| Boc-Val-Cit-PABA |
Boc-Val-Cit-PABA |
870487-09-5 |
| Sitagliptin |
西他列汀 |
486460-32-6 |
| (6S,9S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-2,9-dimethyl- 4,7-dioxo-8-(quinolin-8-ylmethyl)hexahydro-2H- pyrazino[2,1-c][1,2,4]triazine-1(6H)-carboxamide |
1422253-37-9 |
1422253-37-9 |
| (Z)-N-(4-(diethylamino)-2-hydroxybenzylidene)isonicotinohydrazide |
化合物RSVA 405 |
140405-36-3 |
| 1V209 |
1V209 |
1062444-54-5 |
| AT-007 |
AT-007 |
2170729-29-8 |
| ML-180 |
ML-180 |
863588-32-3 |
| THAL-SNS-032 |
THAL-SNS-032 |
2139287-33-3 |
| Lys05 |
COMPONENT: 1391426-22-4 |
1391426-24-6 |
| MC-MMAF |
MC-MMAF |
863971-19-1 |
| AMPRENAVIR |
安普那韦 |
161814-49-9 |
| ARV-771 |
ARV-771 |
1949837-12-0 |
| Encorafenib (LGX818) |
康奈非尼 |
1269440-17-6 |
| LOXO-292 |
塞卡替尼 |
2152628-33-4 |
| RG120 |
艾伏尼布 |
1448347-49-6 |
QQ
微信
